Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.33 |
| ▸ | CNR1 | P21554 | 2/20 | 0.32 |
| ▸ | CNR2 | P34972 | 2/20 | 0.32 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.31 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.30 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29621061 | 1.00 | FAAH (0.33) | FAAHCNR1CNR2TRPV1FFAR1 | |
| SCHEMBL29621420 | 1.00 | FAAH (0.33) | FAAHCNR1CNR2TRPV1FFAR1 | |
| SCHEMBL29621101 | 1.00 | FAAH (0.33) | FAAHCNR1CNR2TRPV1FFAR1 | |
| SCHEMBL29621310 | 1.00 | FAAH (0.33) | FAAHCNR1CNR2TRPV1FFAR1 | |
| SCHEMBL29621397 | 1.00 | FAAH (0.33) | FAAHCNR1CNR2TRPV1FFAR1 | |
| SCHEMBL19458671 | 1.00 | FAAH (0.33) | FAAHCNR1CNR2TRPV1FFAR1 | |
| SCHEMBL29621414 | 1.00 | FAAH (0.33) | FAAHCNR1CNR2TRPV1FFAR1 | |
| SCHEMBL29621017 | 1.00 | FAAH (0.33) | FAAHCNR1CNR2TRPV1FFAR1 | |
| SCHEMBL19458703 | 1.00 | FAAH (0.33) | FAAHCNR1CNR2TRPV1FFAR1 | |
| SCHEMBL29621281 | 1.00 | FAAH (0.33) | FAAHCNR1CNR2TRPV1FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114380673-B | Dialkoxy alkenyl alkoxy methyl ether compound and method for preparing terminal conjugated alkadiene aldehyde compound from same | 信越化学工业株式会社 | 2024-09-13 | — | — | CN | disclosed |
| CN-114380673-A | Dialkoxyalkenylalkoxymethyl ether compounds and process for producing conjugated alkadienal compounds from the same | 信越化学工业株式会社 | 2022-04-22 | — | — | CN | disclosed |
| CN-107304163-B | Method for producing aliphatic aldehyde compound having terminal conjugated diene structure and intermediate for use in said method | 信越化学工业株式会社 | 2020-12-25 | — | — | CN | disclosed |
| EP-3235798-B1 | METHOD OF PRODUCING ALIPHATIC ALDEHYDE COMPOUND HAVING TERMINAL CONJUGATED DIENE STRUCTURE AND INTERMEDIATE THEREFOR | SHINETSU CHEMICAL CO (JP) | 2018-11-07 | — | — | EP | disclosed |
| US-10040742-B2 | Method of producing aliphatic aldehyde compound having terminal conjugated diene structure and intermediate therefor | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2018-08-07 | — | — | US | disclosed |
| EP-3235798-A1 | METHOD OF PRODUCING ALIPHATIC ALDEHYDE COMPOUND HAVING TERMINAL CONJUGATED DIENE STRUCTURE AND INTERMEDIATE THEREFOR | Shin-Etsu Chemical Co., Ltd. (JP) | 2017-10-25 | — | — | EP | disclosed |
| US-20170297987-A1 | METHOD OF PRODUCING ALIPHATIC ALDEHYDE COMPOUND HAVING TERMINAL CONJUGATED DIENE STRUCTURE AND INTERMEDIATE THEREFOR | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170297987-A1 | METHOD OF PRODUCING ALIPHATIC ALDEHYDE COMPOUND HAVING TERMINAL CONJUGATED DIENE STRUCTURE AND INTERMEDIATE THEREFOR | ALDH7A1, ALDH16A1, FAR1 | FAAH 351/4885CNR1 2997/4885CNR2 2753/4885 |
| US-10040742-B2 | Method of producing aliphatic aldehyde compound having terminal conjugated diene structure and intermediate therefor | ALDH7A1, ALDH16A1, FAR1 | FAAH 351/4885CNR1 2997/4885CNR2 2753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.